Small Cell Lung Cancer, New Positive Data on Serpluximab Immunotherapy
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.9 Articles
9 Articles
(Adnkronos) Henlius Biotech Inc. and Accord Healthcare UK announced the results of the Astride study, a randomised open-label, descriptive liaison study conducted in the United States in adult patients with large-stage small cell lung cancer (ES-Sclc).The study informs a notation of...Read MoreThe articleSmall cell lung cancer, new positive data on serplulimb immunotherapy comes from Five Columns Magazine.
(Adnkronos) - Henlius Biotech Inc. and Accord Healthcare UK announced the results of the Astride study, a randomised open-label, descriptive liaison study conducted in the United States in adult patients with extended stage small cell lung cancer (ES-Sclc). The study informs a notation of [...]
notizie.it
(Adnkronos) - Henlius Biotech Inc. and Accord Healthcare UK announced the results of the Astride study, an open-label randomised liaison study
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
